From METS to malaria: RRx-001, a multi-faceted anticancer agent with activity in cerebral malaria
Main Author: | |
---|---|
Publication Date: | 2015 |
Other Authors: | , , , , |
Format: | Article |
Language: | eng |
Source: | Repositório Institucional da FIOCRUZ (ARCA) |
DOI: | 10.1186/s12936-015-0720-5 |
Download full: | https://arca.fiocruz.br/handle/icict/13386 |
Summary: | University of California. Department of Bioengineering. San Diego, CA, USA / Koç University. School of Medicine. Istanbul, Tirkey. |
id |
CRUZ_eb37b535b9f79c24d78cae2c2b47bbc9 |
---|---|
oai_identifier_str |
oai:arca.fiocruz.br:icict/13386 |
network_acronym_str |
CRUZ |
network_name_str |
Repositório Institucional da FIOCRUZ (ARCA) |
repository_id_str |
2135 |
spelling |
Yalcin, OzlemOronsky, BryanCarvalho, Leonardo J. M.Kuypers, Frans A.Scicinski, JanCabrales, Pedro2016-03-29T15:07:09Z2016-03-29T15:07:09Z2015YALCIN, Ozlem et al. From METS to malaria: RRx-001, a multi-faceted anticancer agent with activity in cerebral malaria. Malaria Journal, v. 14, n. 218, p. 1-12, May 2015.1475-2875https://arca.fiocruz.br/handle/icict/1338610.1186/s12936-015-0720-51475-2875engBioMed CentralFrom METS to malaria: RRx-001, a multi-faceted anticancer agent with activity in cerebral malariainfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleUniversity of California. Department of Bioengineering. San Diego, CA, USA / Koç University. School of Medicine. Istanbul, Tirkey.EpicentRx Inc. Mountain View, CA, USA.La Jolla Bioengineering Institute. Center for Malaria Research. San Diego, CA, USA / Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Pesquisa em Malária. Rio de Janeiro, RJ, Brasil.Children’s Hospital Oakland Research Institute. Oakland, CA, USA.EpicentRx Inc. Mountain View, CA, USA.University of California. Department of Bioengineering. San Diego, CA, USA.Background: The survival of malaria parasites, under substantial haem-induced oxidative stress in the red blood cells (RBCs) is dependent on the pentose phosphate pathway (PPP). The PPP is the only source of NADPH in the RBC, essential for the production of reduced glutathione (GSH) and for protection from oxidative stress. Glucose-6-phosphate dehydrogenase (G6PD) deficiency, therefore, increases the vulnerability of erythrocytes to oxidative stress. In Plasmodium, G6PD is combined with the second enzyme of the PPP to create a unique bifunctional enzyme, named glucose-6-phosphate dehydrogenase–6-hosphogluconolactonase (G6PD-6PGL). RRx-001 is a novel, systemically non-toxic, epigenetic anticancer agent currently in Phase 2 clinical development for multiple tumour types, with activity mediated through increased nitric oxide (NO) production and PPP inhibition. The inhibition of G6PD and NO overproduction induced by RRx-001 suggested its application in cerebral malaria (CM). Methods: Plasmodium berghei ANKA (PbA) infection in C57BL/6 mice is an experimental model of cerebral malaria (ECM) with several similar pathological features to human CM. This study uses intravital microscopy methods with a closed cranial window model to quantify cerebral haemodynamic changes and leukocyte adhesion to endothelial cells in ECM. Results: RRx-001 had both single agent anti-parasitic activity and significantly increased the efficacy of artemether. In addition, RRx-001 preserved cerebral perfusion and reduced inflammation alone or combined with artemether. RRx-001's effects were associated with inhibition of PPP (G6PD and G6PD-6PGL) and by improvements in microcirculatory flow, which may be related to the NO donating properties of RRx-001. Conclusion: The results indicate that RRx-001 could be used to potentiate the anti-malarial action of artemisinin, particularly on resistant strains, and to prevent infection.Pial microcircultationAnemiaG6PDNitric oxideEpigeneticRRx-001Malária CerebralAnemiaÓxido NítricoEpigênese Genéticainfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txtlicense.txttext/plain; charset=utf-82991https://arca.fiocruz.br/bitstreams/5b6a6579-83fe-40b5-9999-5721ea04b967/download5a560609d32a3863062d77ff32785d58MD51falseAnonymousREADORIGINALleonardo_carvalho_etal_IOC_2015.pdfleonardo_carvalho_etal_IOC_2015.pdfapplication/pdf3678147https://arca.fiocruz.br/bitstreams/88784abd-08ab-4430-a195-fb10c0bce672/download1d6784f80378fd9caea19c8ac4f4aab1MD52trueAnonymousREADTEXTleonardo_carvalho_etal_IOC_2015.pdf.txtleonardo_carvalho_etal_IOC_2015.pdf.txtExtracted texttext/plain55358https://arca.fiocruz.br/bitstreams/539673e4-9b00-4a8c-af1a-f3e7c3d72c25/download0b6a00f57d477579212e82a73293418dMD56falseAnonymousREADTHUMBNAILCapa_page-0001.jpgCapa_page-0001.jpgimage/jpeg1014368https://arca.fiocruz.br/bitstreams/173ea370-63c3-4549-a2d9-4c4dd09f96b9/download1b0af8dea9b2f4b69fbc2c4001888fadMD54falseAnonymousREADleonardo_carvalho_etal_IOC_2015.pdf.jpgleonardo_carvalho_etal_IOC_2015.pdf.jpgGenerated Thumbnailimage/jpeg5841https://arca.fiocruz.br/bitstreams/b7bfd0c9-529b-46fa-963e-80146f0815ec/downloadbf655a9ab9881870b22daf4f8f56d61eMD57falseAnonymousREADicict/133862025-07-29 23:45:24.009open.accessoai:arca.fiocruz.br:icict/13386https://arca.fiocruz.brRepositório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352025-07-30T02:45:24Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)falseQ0VTU8ODTyBOw4NPIEVYQ0xVU0lWQSBERSBESVJFSVRPUyBBVVRPUkFJUwoKQW8gYWNlaXRhciBvcyBURVJNT1MgZSBDT05EScOHw5VFUyBkZXN0YSBDRVNTw4NPLCBvIEFVVE9SIGUvb3UgVElUVUxBUiBkZSBkaXJlaXRvcwphdXRvcmFpcyBzb2JyZSBhIE9CUkEgZGUgcXVlIHRyYXRhIGVzdGUgZG9jdW1lbnRvOgoKKDEpIENFREUgZSBUUkFOU0ZFUkUsIHRvdGFsIGUgZ3JhdHVpdGFtZW50ZSwgw6AgRklPQ1JVWiAtIEZVTkRBw4fDg08gT1NXQUxETyBDUlVaLCBlbQpjYXLDoXRlciBwZXJtYW5lbnRlLCBpcnJldm9nw6F2ZWwgZSBOw4NPIEVYQ0xVU0lWTywgdG9kb3Mgb3MgZGlyZWl0b3MgcGF0cmltb25pYWlzIE7Dg08KQ09NRVJDSUFJUyBkZSB1dGlsaXphw6fDo28gZGEgT0JSQSBhcnTDrXN0aWNhIGUvb3UgY2llbnTDrWZpY2EgaW5kaWNhZGEgYWNpbWEsIGluY2x1c2l2ZSBvcyBkaXJlaXRvcwpkZSB2b3ogZSBpbWFnZW0gdmluY3VsYWRvcyDDoCBPQlJBLCBkdXJhbnRlIHRvZG8gbyBwcmF6byBkZSBkdXJhw6fDo28gZG9zIGRpcmVpdG9zIGF1dG9yYWlzLCBlbQpxdWFscXVlciBpZGlvbWEgZSBlbSB0b2RvcyBvcyBwYcOtc2VzOwoKKDIpIEFDRUlUQSBxdWUgYSBjZXNzw6NvIHRvdGFsIG7Do28gZXhjbHVzaXZhLCBwZXJtYW5lbnRlIGUgaXJyZXZvZ8OhdmVsIGRvcyBkaXJlaXRvcyBhdXRvcmFpcwpwYXRyaW1vbmlhaXMgbsOjbyBjb21lcmNpYWlzIGRlIHV0aWxpemHDp8OjbyBkZSBxdWUgdHJhdGEgZXN0ZSBkb2N1bWVudG8gaW5jbHVpLCBleGVtcGxpZmljYXRpdmFtZW50ZSwKb3MgZGlyZWl0b3MgZGUgZGlzcG9uaWJpbGl6YcOnw6NvIGUgY29tdW5pY2HDp8OjbyBww7pibGljYSBkYSBPQlJBLCBlbSBxdWFscXVlciBtZWlvIG91IHZlw61jdWxvLAppbmNsdXNpdmUgZW0gUmVwb3NpdMOzcmlvcyBEaWdpdGFpcywgYmVtIGNvbW8gb3MgZGlyZWl0b3MgZGUgcmVwcm9kdcOnw6NvLCBleGliacOnw6NvLCBleGVjdcOnw6NvLApkZWNsYW1hw6fDo28sIHJlY2l0YcOnw6NvLCBleHBvc2nDp8OjbywgYXJxdWl2YW1lbnRvLCBpbmNsdXPDo28gZW0gYmFuY28gZGUgZGFkb3MsIHByZXNlcnZhw6fDo28sIGRpZnVzw6NvLApkaXN0cmlidWnDp8OjbywgZGl2dWxnYcOnw6NvLCBlbXByw6lzdGltbywgdHJhZHXDp8OjbywgZHVibGFnZW0sIGxlZ2VuZGFnZW0sIGluY2x1c8OjbyBlbSBub3ZhcyBvYnJhcyBvdQpjb2xldMOibmVhcywgcmV1dGlsaXphw6fDo28sIGVkacOnw6NvLCBwcm9kdcOnw6NvIGRlIG1hdGVyaWFsIGRpZMOhdGljbyBlIGN1cnNvcyBvdSBxdWFscXVlciBmb3JtYSBkZQp1dGlsaXphw6fDo28gbsOjbyBjb21lcmNpYWw7CgooMykgUkVDT05IRUNFIHF1ZSBhIGNlc3PDo28gYXF1aSBlc3BlY2lmaWNhZGEgY29uY2VkZSDDoCBGSU9DUlVaIC0gRlVOREHDh8ODTyBPU1dBTERPCkNSVVogbyBkaXJlaXRvIGRlIGF1dG9yaXphciBxdWFscXVlciBwZXNzb2Eg4oCTIGbDrXNpY2Egb3UganVyw61kaWNhLCBww7pibGljYSBvdSBwcml2YWRhLCBuYWNpb25hbCBvdQplc3RyYW5nZWlyYSDigJMgYSBhY2Vzc2FyIGUgdXRpbGl6YXIgYW1wbGFtZW50ZSBhIE9CUkEsIHNlbSBleGNsdXNpdmlkYWRlLCBwYXJhIHF1YWlzcXVlcgpmaW5hbGlkYWRlcyBuw6NvIGNvbWVyY2lhaXM7CgooNCkgREVDTEFSQSBxdWUgYSBvYnJhIMOpIGNyaWHDp8OjbyBvcmlnaW5hbCBlIHF1ZSDDqSBvIHRpdHVsYXIgZG9zIGRpcmVpdG9zIGFxdWkgY2VkaWRvcyBlIGF1dG9yaXphZG9zLApyZXNwb25zYWJpbGl6YW5kby1zZSBpbnRlZ3JhbG1lbnRlIHBlbG8gY29udGXDumRvIGUgb3V0cm9zIGVsZW1lbnRvcyBxdWUgZmF6ZW0gcGFydGUgZGEgT0JSQSwKaW5jbHVzaXZlIG9zIGRpcmVpdG9zIGRlIHZveiBlIGltYWdlbSB2aW5jdWxhZG9zIMOgIE9CUkEsIG9icmlnYW5kby1zZSBhIGluZGVuaXphciB0ZXJjZWlyb3MgcG9yCmRhbm9zLCBiZW0gY29tbyBpbmRlbml6YXIgZSByZXNzYXJjaXIgYSBGSU9DUlVaIC0gRlVOREHDh8ODTyBPU1dBTERPIENSVVogZGUKZXZlbnR1YWlzIGRlc3Blc2FzIHF1ZSB2aWVyZW0gYSBzdXBvcnRhciwgZW0gcmF6w6NvIGRlIHF1YWxxdWVyIG9mZW5zYSBhIGRpcmVpdG9zIGF1dG9yYWlzIG91CmRpcmVpdG9zIGRlIHZveiBvdSBpbWFnZW0sIHByaW5jaXBhbG1lbnRlIG5vIHF1ZSBkaXogcmVzcGVpdG8gYSBwbMOhZ2lvIGUgdmlvbGHDp8O1ZXMgZGUgZGlyZWl0b3M7CgooNSkgQUZJUk1BIHF1ZSBjb25oZWNlIGEgUG9sw610aWNhIEluc3RpdHVjaW9uYWwgZGUgQWNlc3NvIEFiZXJ0byBkYSBGSU9DUlVaIC0gRlVOREHDh8ODTwpPU1dBTERPIENSVVogZSBhcyBkaXJldHJpemVzIHBhcmEgbyBmdW5jaW9uYW1lbnRvIGRvIHJlcG9zaXTDs3JpbyBpbnN0aXR1Y2lvbmFsIEFSQ0EuCgpBIFBvbMOtdGljYSBJbnN0aXR1Y2lvbmFsIGRlIEFjZXNzbyBBYmVydG8gZGEgRklPQ1JVWiAtIEZVTkRBw4fDg08gT1NXQUxETyBDUlVaIHJlc2VydmEKZXhjbHVzaXZhbWVudGUgYW8gQVVUT1Igb3MgZGlyZWl0b3MgbW9yYWlzIGUgb3MgdXNvcyBjb21lcmNpYWlzIHNvYnJlIGFzIG9icmFzIGRlIHN1YSBhdXRvcmlhCmUvb3UgdGl0dWxhcmlkYWRlLCBzZW5kbyBvcyB0ZXJjZWlyb3MgdXN1w6FyaW9zIHJlc3BvbnPDoXZlaXMgcGVsYSBhdHJpYnVpw6fDo28gZGUgYXV0b3JpYSBlIG1hbnV0ZW7Dp8OjbwpkYSBpbnRlZ3JpZGFkZSBkYSBPQlJBIGVtIHF1YWxxdWVyIHV0aWxpemHDp8Ojby4KCkEgUG9sw610aWNhIEluc3RpdHVjaW9uYWwgZGUgQWNlc3NvIEFiZXJ0byBkYSBGSU9DUlVaIC0gRlVOREHDh8ODTyBPU1dBTERPIENSVVoKcmVzcGVpdGEgb3MgY29udHJhdG9zIGUgYWNvcmRvcyBwcmVleGlzdGVudGVzIGRvcyBBdXRvcmVzIGNvbSB0ZXJjZWlyb3MsIGNhYmVuZG8gYW9zIEF1dG9yZXMKaW5mb3JtYXIgw6AgSW5zdGl0dWnDp8OjbyBhcyBjb25kacOnw7VlcyBlIG91dHJhcyByZXN0cmnDp8O1ZXMgaW1wb3N0YXMgcG9yIGVzdGVzIGluc3RydW1lbnRvcy4K |
dc.title.none.fl_str_mv |
From METS to malaria: RRx-001, a multi-faceted anticancer agent with activity in cerebral malaria |
title |
From METS to malaria: RRx-001, a multi-faceted anticancer agent with activity in cerebral malaria |
spellingShingle |
From METS to malaria: RRx-001, a multi-faceted anticancer agent with activity in cerebral malaria Yalcin, Ozlem Pial microcircultation Anemia G6PD Nitric oxide Epigenetic RRx-001 Malária Cerebral Anemia Óxido Nítrico Epigênese Genética |
title_short |
From METS to malaria: RRx-001, a multi-faceted anticancer agent with activity in cerebral malaria |
title_full |
From METS to malaria: RRx-001, a multi-faceted anticancer agent with activity in cerebral malaria |
title_fullStr |
From METS to malaria: RRx-001, a multi-faceted anticancer agent with activity in cerebral malaria |
title_full_unstemmed |
From METS to malaria: RRx-001, a multi-faceted anticancer agent with activity in cerebral malaria |
title_sort |
From METS to malaria: RRx-001, a multi-faceted anticancer agent with activity in cerebral malaria |
author |
Yalcin, Ozlem |
author_facet |
Yalcin, Ozlem Oronsky, Bryan Carvalho, Leonardo J. M. Kuypers, Frans A. Scicinski, Jan Cabrales, Pedro |
author_role |
author |
author2 |
Oronsky, Bryan Carvalho, Leonardo J. M. Kuypers, Frans A. Scicinski, Jan Cabrales, Pedro |
author2_role |
author author author author author |
dc.contributor.author.fl_str_mv |
Yalcin, Ozlem Oronsky, Bryan Carvalho, Leonardo J. M. Kuypers, Frans A. Scicinski, Jan Cabrales, Pedro |
dc.subject.en.none.fl_str_mv |
Pial microcircultation Anemia G6PD Nitric oxide Epigenetic RRx-001 |
topic |
Pial microcircultation Anemia G6PD Nitric oxide Epigenetic RRx-001 Malária Cerebral Anemia Óxido Nítrico Epigênese Genética |
dc.subject.decs.none.fl_str_mv |
Malária Cerebral Anemia Óxido Nítrico Epigênese Genética |
description |
University of California. Department of Bioengineering. San Diego, CA, USA / Koç University. School of Medicine. Istanbul, Tirkey. |
publishDate |
2015 |
dc.date.issued.fl_str_mv |
2015 |
dc.date.accessioned.fl_str_mv |
2016-03-29T15:07:09Z |
dc.date.available.fl_str_mv |
2016-03-29T15:07:09Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.citation.fl_str_mv |
YALCIN, Ozlem et al. From METS to malaria: RRx-001, a multi-faceted anticancer agent with activity in cerebral malaria. Malaria Journal, v. 14, n. 218, p. 1-12, May 2015. |
dc.identifier.uri.fl_str_mv |
https://arca.fiocruz.br/handle/icict/13386 |
dc.identifier.issn.none.fl_str_mv |
1475-2875 |
dc.identifier.doi.none.fl_str_mv |
10.1186/s12936-015-0720-5 |
dc.identifier.eissn.none.fl_str_mv |
1475-2875 |
identifier_str_mv |
YALCIN, Ozlem et al. From METS to malaria: RRx-001, a multi-faceted anticancer agent with activity in cerebral malaria. Malaria Journal, v. 14, n. 218, p. 1-12, May 2015. 1475-2875 10.1186/s12936-015-0720-5 |
url |
https://arca.fiocruz.br/handle/icict/13386 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.publisher.none.fl_str_mv |
BioMed Central |
publisher.none.fl_str_mv |
BioMed Central |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da FIOCRUZ (ARCA) instname:Fundação Oswaldo Cruz (FIOCRUZ) instacron:FIOCRUZ |
instname_str |
Fundação Oswaldo Cruz (FIOCRUZ) |
instacron_str |
FIOCRUZ |
institution |
FIOCRUZ |
reponame_str |
Repositório Institucional da FIOCRUZ (ARCA) |
collection |
Repositório Institucional da FIOCRUZ (ARCA) |
bitstream.url.fl_str_mv |
https://arca.fiocruz.br/bitstreams/5b6a6579-83fe-40b5-9999-5721ea04b967/download https://arca.fiocruz.br/bitstreams/88784abd-08ab-4430-a195-fb10c0bce672/download https://arca.fiocruz.br/bitstreams/539673e4-9b00-4a8c-af1a-f3e7c3d72c25/download https://arca.fiocruz.br/bitstreams/173ea370-63c3-4549-a2d9-4c4dd09f96b9/download https://arca.fiocruz.br/bitstreams/b7bfd0c9-529b-46fa-963e-80146f0815ec/download |
bitstream.checksum.fl_str_mv |
5a560609d32a3863062d77ff32785d58 1d6784f80378fd9caea19c8ac4f4aab1 0b6a00f57d477579212e82a73293418d 1b0af8dea9b2f4b69fbc2c4001888fad bf655a9ab9881870b22daf4f8f56d61e |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 MD5 MD5 |
repository.name.fl_str_mv |
Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ) |
repository.mail.fl_str_mv |
repositorio.arca@fiocruz.br |
_version_ |
1839716238526251008 |